Votruba Michal 4
4 · BioXcel Therapeutics, Inc. · Filed Jun 19, 2019
Insider Transaction Report
Form 4
Votruba Michal
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-05-23+4,700→ 4,700 totalExercise: $10.04Exp: 2029-05-23→ Common Stock (4,700 underlying) - Other
Stock Option (Right to Buy)
2019-05-23−4,700→ 0 totalExercise: $10.04Exp: 2029-05-23→ Common Stock (4,700 underlying)
Footnotes (2)
- [F1]The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund ("RSJ") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person does not beneficially own any of the securities reported herein.
- [F2]The option will vest in full and become exercisable on the first anniversary of the grant date.